Aaysha Cader
@aayshacader
Followers
9K
Following
73K
Media
2K
Statuses
32K
Cardiology•@Oxford_NDPH MSc’22•@PCRonline JC•#ACCEarlyCareer Int’l WG Chair•@SCAI IHD Council•#EAPCI Comm•@worldheartfed EL•@APSCYoung •AE @ESC_Journals @jaha
United Kingdom
Joined September 2018
Absolutely honoured to have done this for @EuroInterventio .Thank u for this incredible experience .@DFCapodanno @EuroInterventio & for all your hard work behind the scenes! @RonnieLass @Syllho & team!. 🎙️Episode 1 is out! .🎧here @Spotify @ApplePodcasts
🎙️ Our new podcast Turning Point launches today!.In Episode 1, Patrick W. Serruys joins host @aayshacader to reflect on a life of bold choices, innovation & mentorship. 🎧 Listen now:
11
15
57
RT @PCRonline: #ESCCongress 🇪🇸 2025: Tailored antiplatelet therapy for complex high-risk PCI. 🔗 @NicolaRyanI1 revie….
0
5
0
RT @PCRonline: #ESCCongress 🇪🇸 2025: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery dise….
0
9
0
RT @WomenAs1: 👏 Congratulations to @Drroxmehran, co-founder of Women As One, on receiving the ESC Gold Medal, @escardio's highest honor. H….
0
12
0
RT @drjohnm: Dear #ESCCongress -- thx for such a great meeting. We all have a lot of work to do digging into all these trials. There are so….
0
30
0
RT @sbrugaletta: I totally agree. there is still no evidence and maybe harm in less < 1month ASA withdrawn but evidence to have ASA free st….
0
6
0
RT @WomenAs1: RISE @ ESC Congress 2025 Program Director Dr. @lieslzuhlke inspires us to continue to crack even more ceilings together! #Mon….
0
3
0
RT @PCRonline: #ESCCongress 🇪🇸 2025 : Duration of DAPT in ACS: The DUAL-ACS Trial. 📺 @ANazmiCalik interviews David….
0
19
0
RT @DLBHATTMD: Practice-changing meta-analysis presented by @vlgmrc at #ESCCongress2025 and published in @TheLancet. .
0
55
0
RT @ZainabDakhil2: Honored to join #ESCTV conversation @escardio #ESCCongress to discuss a critical question:Can the world afford the futur….
0
11
0
RT @slumberbell: Inspiring Made-Easy Series session at the #ESCTV stage, together with @worldheartfed on gender disparities🫀. Chair: @mirva….
0
12
0
RT @DrDamluji: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction: @NEJM . 🥸 I am not sure the association here is stro….
0
45
0
RT @DrDamluji: Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: @NEJM . 🥸 Mavacamten is a no go for non-obstructive HO….
0
53
0
RT @DrBendary: DIGIT-HF trial has started a snowball effect in heart failure research! Are we in front of the fifth pillar in HFrEF? 🤔 . W….
0
18
0
RT @ZainabDakhil2: Powerful presentation by @Drroxmehran @escardio #ESCcongress in Great Debate on rise of AI avatars in cardiology:will t….
0
7
0
RT @DrMarthaGulati: Our paper was simultaneously released with our presentation at #ESCCongress .♥️women remain underrepresented in Clinica….
0
58
0
RT @DrMarthaGulati: Please feel free to join us tonight for a drink!.All are welcome!.#ESCCongress #meetup #tweetup.Come to the 7th floor!….
0
7
0
RT @DrPascalMeier: News from the #ESCCongress. Striking sex differences in beta-blocker effects post-MI without reduced EF 🫀. Women saw no….
0
15
0
RT @Drroxmehran: 💧#AQUATIC #ESCCongress 2025:.📍872 CCS high-risk pts w/ hx stent (>6m) on OAC.✨RCT: ASA vs placebo (+OAC).❌ ⬆️MACE (HR 1.53….
0
22
0
RT @purviparwani: Some great slides from #Guidelines discussion on triglycerides reduction. Check them out. 📉 Not all TG-lowering thera….
0
74
0
RT @purviparwani: #ESCCongress .Great late breaker presentation by @mmamas1973 . 1️⃣ SURMOUNT-5 (72 weeks, n=751):.🔻 Tirzepatide led to sup….
0
83
0